Form 8-K - Current report:
SEC Accession No. 0000899923-21-000097
Filing Date
2021-12-14
Accepted
2021-12-14 16:13:15
Documents
16
Period of Report
2021-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20211214.htm   iXBRL 8-K 39925
2 EX-99.1 exhibit991_lambertcoo.htm EX-99.1 9268
6 GRAPHIC exhibit991_lambertcoo001.jpg GRAPHIC 177424
7 GRAPHIC exhibit991_lambertcoo002.jpg GRAPHIC 218587
8 GRAPHIC exhibit991_lambertcoo003.jpg GRAPHIC 144038
  Complete submission text file 0000899923-21-000097.txt   933947

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20211214.xsd EX-101.SCH 1896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20211214_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20211214_pre.xml EX-101.PRE 12634
9 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20211214_htm.xml XML 10816
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 211491131
SIC: 2835 In Vitro & In Vivo Diagnostic Substances